Published in J Exp Med on June 05, 2000
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 4.34
A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med (2005) 2.80
Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med (2002) 1.48
T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest (2005) 1.45
Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44
Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease. Biologics (2007) 1.41
Viral trigger for type 1 diabetes: pros and cons. Diabetes (2008) 1.33
The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med (2002) 1.24
Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J Virol (2001) 1.18
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med (2001) 1.17
Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest (2003) 1.14
Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11
Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions. Immunity (2013) 1.09
Mouse Models for Type 1 Diabetes. Drug Discov Today Dis Models (2009) 1.09
Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol (2012) 1.03
Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nat Med (2011) 1.03
Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol (2006) 1.00
Dysregulation of immune homeostasis in autoimmune diseases. Nat Med (2012) 0.98
Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology (2006) 0.97
On the role of the innate immunity in autoimmune disease. J Exp Med (2001) 0.97
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood (2007) 0.96
Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. Immunology (2003) 0.93
Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin Exp Immunol (2010) 0.87
ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system. Nat Immunol (2012) 0.85
Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis. J Autoimmun (2010) 0.84
Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to beta cell damage. J Immunol (2009) 0.83
Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis. Clin Exp Immunol (2002) 0.83
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. Proc Natl Acad Sci U S A (2014) 0.82
Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Front Immunol (2013) 0.82
Immunologic aspect of ovarian cancer and p53 as tumor antigen. J Transl Med (2005) 0.80
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity. Curr Immunol Rev (2005) 0.79
Different toll-like receptor stimuli have a profound impact on cytokines required to break tolerance and induce autoimmunity. PLoS One (2011) 0.79
TLR7 and TLR9 ligands regulate antigen presentation by macrophages. Int Immunol (2015) 0.77
Co-administration of CD40 agonistic antibody and antigen fails to overcome the induction of oral tolerance. Immunology (2004) 0.76
Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvant. PLoS One (2014) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med (1996) 9.31
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (1989) 7.52
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol (1998) 6.83
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 6.49
Following a diabetogenic T cell from genesis through pathogenesis. Cell (1993) 6.46
Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell (1990) 6.33
Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16
The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today (1992) 5.93
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science (1999) 4.97
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell (1993) 4.59
High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell (1994) 4.34
The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity (1996) 4.02
Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat Med (1999) 3.29
Models of T cell anergy: is there a common molecular mechanism? J Exp Med (1996) 3.07
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med (1999) 2.77
Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity (1995) 2.29
T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol (1993) 2.25
CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science (1996) 2.21
Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J Exp Med (1973) 2.15
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05
Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med (1996) 1.78
Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med (1998) 1.70
The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today (1998) 1.45
Infection breaks T-cell tolerance. Nature (1992) 1.41
Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J Immunol (1999) 1.34
Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant. J Exp Med (1998) 1.20
CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol (1999) 1.11
Bacterial lipopolysaccharide (endotoxin) interferes with the induction of tolerance and primes thymus-derived lymphocytes. J Immunol (1981) 0.97
Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol Rev (1996) 0.86
Dendritic cells and T lymphocytes: developmental and functional interactions. Ciba Found Symp (1997) 0.80
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell (1993) 9.84
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol (2001) 6.78
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 6.49
Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science (2000) 5.84
Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science (1995) 5.27
T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity (2001) 4.62
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature (2000) 4.08
ICOS is essential for effective T-helper-cell responses. Nature (2001) 4.01
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature (2001) 3.99
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell (2001) 3.80
IgA production without mu or delta chain expression in developing B cells. Nat Immunol (2001) 3.26
Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol (2005) 3.12
Gastrointestinal duplications. J Pediatr Surg (2003) 3.09
Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell (1993) 3.07
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer (2006) 3.05
Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (1994) 2.86
25 years' experience with lymphangiomas in children. J Pediatr Surg (1999) 2.85
Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature (1985) 2.84
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med (1999) 2.77
CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood (1997) 2.71
On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A (1996) 2.55
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med (2000) 2.51
Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med (1997) 2.47
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol (2008) 2.37
Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax (2004) 2.36
Appendicitis in children: current therapeutic recommendations. J Pediatr Surg (1990) 2.30
Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity (1997) 2.25
Selection of the T cell repertoire. Annu Rev Immunol (1999) 2.21
T cell-specific gamma genes in C57BL/10 mice. Sequence and expression of new constant and variable region genes. J Exp Med (1986) 2.20
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med (1996) 2.14
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol (2000) 2.13
Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity (1996) 2.08
The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity (1998) 2.06
Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (1995) 2.01
OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity (1999) 1.93
The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med (1998) 1.88
Deletion of self-reactive T cells before entry into the thymus medulla. Nature (1988) 1.88
Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science (2001) 1.87
A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol (2001) 1.85
Obstructive sleep apnoea and perioperative complications in bariatric patients. Br J Anaesth (2010) 1.85
Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J Immunol (1997) 1.84
Induction of long-lived germinal centers associated with persisting antigen after viral infection. J Exp Med (1996) 1.80
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med (1997) 1.77
Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A (2000) 1.73
Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol (1997) 1.73
Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med (1998) 1.70
Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J Infect Dis (2000) 1.68
Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med (1998) 1.65
Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol Rev (1979) 1.64
Computed tomography in abdominal tuberculosis. Br J Radiol (1999) 1.60
On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med (1997) 1.59
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity (1999) 1.56
Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J Immunol (1993) 1.55
Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med (1997) 1.55
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med (2000) 1.54
Dendritic cells efficiently induce protective antiviral immunity. J Virol (1998) 1.53
Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med (2000) 1.50
Mature T cell reactivity altered by peptide agonist that induces positive selection. J Exp Med (1996) 1.50
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med (2000) 1.46
The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol (1997) 1.46
Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J Immunol (1994) 1.45
Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity (2000) 1.44
Epidermolysis bullosa simplex with mottled pigmentation. J Am Acad Dermatol (1989) 1.44
Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci U S A (1994) 1.43
T cell receptor variable gene usage in a specific cytotoxic T cell response. Primary structure of the antigen-MHC receptor of four hapten-specific cytotoxic T cell clones. J Exp Med (1987) 1.39
Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity (1997) 1.39
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism. Chest (1991) 1.37
On T cell memory: arguments for antigen dependence. Immunol Rev (1996) 1.35
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc Natl Acad Sci U S A (1999) 1.35
Pleiotropic functions of a Streptomyces pristinaespiralis autoregulator receptor in development, antibiotic biosynthesis, and expression of a superoxide dismutase. J Biol Chem (2001) 1.33
Roles of macrophages in measles virus infection of genetically modified mice. J Virol (2001) 1.33
Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Eur J Immunol (1994) 1.32
Duration and strength of extracellular signal-regulated kinase signals are altered during positive versus negative thymocyte selection. J Immunol (2001) 1.32
Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci U S A (2000) 1.32
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med (2000) 1.31
Functional management of an antiviral cytotoxic T-cell response. J Virol (1997) 1.30
Should malrotation in children be treated differently according to age? J Pediatr Surg (2000) 1.29
Homeostatic regulation of CD8+ T cells by perforin. Eur J Immunol (1999) 1.29
CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability. J Exp Med (2000) 1.29
Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc Natl Acad Sci U S A (2001) 1.28
Prevalence of antimicrobial resistance genes in Listeria monocytogenes isolated from dairy farms. Foodborne Pathog Dis (2005) 1.28
Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol (2008) 1.26
Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics (1998) 1.25
Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol (1996) 1.25
Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol (1989) 1.24
Prenatal adverse effects of nicotine on the developing brain. Prog Brain Res (1988) 1.23